glp 1 agonist dementia GLP-1 receptor diabetes medications linked to reduced risk GLP-1 and Alzheimer's Disease: Research
Description
CL: Writing review and editing
Girish PJ, Abdelmalak BB, Weigal WA, et al
Glucagon-like peptide-1 receptor agonist prevented the progression of hepatocellular carcinoma in a mouse model of nonalcoholic Steatohepatitis
Currently, GLP-1 receptor agonist products on the market are all injectable forms
Blood 125 , 284295 (2015)
Efficacy and safety of liraglutide 3.0 mg in individuals with overweight or obesity and type 2 diabetes treated with basal insulin: the scale insulin randomized controlled trial
